|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1993-3-25
|
|
pubmed:abstractText |
A retrospective analysis on HODGKIN'S DISEASE (HD) was finalized to see if changing the management and therapy during the years we improved the cure rate of lymphomas and reduced the incidence of side effects due to therapy. Up to twenty years' experience was based in two major therapeutic periods: the first included patients observed between 1970 and June 1980 and the second between July 1980 and December 1987. Significant differences between the two periods were the reduction of splenectomies as staging procedure, the reduction of radiation dose and extension and the sequential use of MOPP/ABVD instead of MOPP alone.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0390-6078
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
77
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
487-93
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:1283856-Adolescent,
pubmed-meshheading:1283856-Adult,
pubmed-meshheading:1283856-Aged,
pubmed-meshheading:1283856-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:1283856-Bleomycin,
pubmed-meshheading:1283856-Combined Modality Therapy,
pubmed-meshheading:1283856-Dacarbazine,
pubmed-meshheading:1283856-Doxorubicin,
pubmed-meshheading:1283856-Female,
pubmed-meshheading:1283856-Hodgkin Disease,
pubmed-meshheading:1283856-Humans,
pubmed-meshheading:1283856-Male,
pubmed-meshheading:1283856-Mechlorethamine,
pubmed-meshheading:1283856-Middle Aged,
pubmed-meshheading:1283856-Neoplasms, Second Primary,
pubmed-meshheading:1283856-Prednisone,
pubmed-meshheading:1283856-Procarbazine,
pubmed-meshheading:1283856-Prognosis,
pubmed-meshheading:1283856-Radiotherapy,
pubmed-meshheading:1283856-Remission Induction,
pubmed-meshheading:1283856-Retrospective Studies,
pubmed-meshheading:1283856-Survival Analysis,
pubmed-meshheading:1283856-Survival Rate,
pubmed-meshheading:1283856-Vinblastine,
pubmed-meshheading:1283856-Vincristine
|
|
pubmed:articleTitle |
Hodgkin's disease: summary of twenty years' experience.
|
|
pubmed:affiliation |
Istituto di Ematologia, Università di Bologna, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
